Quality of Life of Children With Sickle Cell Disease Who Are Getting Chronic Transfusions With a Lifeport

Completed

Conditions studied: Anemia, Sickle Cell

In brief

This study is being done to see what impact having a Lifeport device has on quality of life for children with sickle cell who are getting chronic transfusions, from the child's perspective.

Key facts

Study ID

NCT00246077

Run by

Children's Mercy Hospital Kansas City

People needed

5

Starts

2005-10-01

Expected to finish

2005-12-01

Last updated by the study team

2007-04-11

Who can join

Age: 8 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Individuals with a diagnosis of sickle cell disease between the ages of 8 \& 18 years
• currently receiving chronic transfusion therapy via a Lifeport device
• Individuals have been utilizing the Lifeport for at least 6 months and no more than 18 months
• Individuals have received transfusions previously using conventional transfusion therapy (simple or exchange transfusions)
• Individuals have permission of parents (when applicable) and assent

You may not qualify if…

• Individuals who, in the opinion of the study staff, would suffer negative consequence, psychosocial trauma, or undue stress as a result of participation

Where it is running

• The Children's Mercy Hospital — Kansas City, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.